Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding complications in the Netherlands.
Appelman EM, Martens ESL, Burger DM, van Gelder T, van der Hulle T, van Rein N, Klok FA. Appelman EM, et al. Among authors: van rein n. Thromb Res. 2025 Jan;245:109232. doi: 10.1016/j.thromres.2024.109232. Epub 2024 Dec 2. Thromb Res. 2025. PMID: 39643974 No abstract available.
External validation of the Leiden Thrombosis Recurrence Risk Prediction models (L-TRRiP) for the prediction of recurrence after a first venous thrombosis in the Heart and Vascular Health study.
Burggraaf-van Delft JLI, Wiggins KL, van Rein N, le Cessie S, Smith NL, Cannegieter SC. Burggraaf-van Delft JLI, et al. Among authors: van rein n. Res Pract Thromb Haemost. 2024 Oct 29;8(8):102610. doi: 10.1016/j.rpth.2024.102610. eCollection 2024 Nov. Res Pract Thromb Haemost. 2024. PMID: 39640909 Free PMC article.
Erratum to 'Performance of Risk Scores in Predicting Major Bleeding in Left Ventricular Assist Device (LVAD) Recipients: a Comparative External Validation. '[Res Pract Thromb Haemost. 2024;8:e102437].
van der Horst SFB, de Jong Y, van Rein N, Jukema JW, Palmen M, Janssen E, Bonneville EF, Klok FA, Huisman MV, Tops LF, den Exter PL. van der Horst SFB, et al. Among authors: van rein n. Res Pract Thromb Haemost. 2024 Aug 30;8(6):102558. doi: 10.1016/j.rpth.2024.102558. eCollection 2024 Aug. Res Pract Thromb Haemost. 2024. PMID: 39282628 Free PMC article.
Performance of risk scores in predicting major bleeding in left ventricular assist device recipients: a comparative external validation.
van der Horst SFB, de Jong Y, van Rein N, Jukema JW, Palmen M, Janssen E, Bonneville EF, Klok FA, Huisman MV, Tops LF, den Exter PL. van der Horst SFB, et al. Among authors: van rein n. Res Pract Thromb Haemost. 2024 May 6;8(4):102437. doi: 10.1016/j.rpth.2024.102437. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38953051 Free PMC article.
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial.
Burggraaf-van Delft JLI, van Rein N, Bemelmans RHH, van den Berg JK, Bruggeman CY, Cloos-van Balen M, Coppens M, Eefting M, Ende-Verhaar Y, van Es N, van Guldener C, de Jong WK, Kleijwegt F, Koster T, Kroon C, Kuipers S, Leentjens J, Luijten D, Mairuhu ATA, Meijer K, van de Ree MA, Roos R, Schrover I, Swart-Heikens J, van der Velden AWG, van den Akker-van Marle EM, le Cessie S, Geersing GJ, Middeldorp S, Huisman MV, Klok FA, Cannegieter SC; L-TRRiP investigators. Burggraaf-van Delft JLI, et al. Among authors: van rein n. BMJ Open. 2024 Mar 23;14(3):e078676. doi: 10.1136/bmjopen-2023-078676. BMJ Open. 2024. PMID: 38521524 Free PMC article.
52 results